Ribosomal and hematopoietic defects in induced pluripotent stem cells derived from Diamond Blackfan anemia patients.
about
Ribosomopathies: how a common root can cause a tree of pathologiesInduced pluripotent stem cells in hematology: current and future applicationsRegulatory Roles of Rpl22 in Hematopoiesis: An Old Dog with New TricksModeling Human Bone Marrow Failure Syndromes Using Pluripotent Stem Cells and Genome EngineeringAltered translation of GATA1 in Diamond-Blackfan anemia.Marrow failure: a window into ribosome biologyRibosomal proteins: functions beyond the ribosomep53-Independent cell cycle and erythroid differentiation defects in murine embryonic stem cells haploinsufficient for Diamond Blackfan anemia-proteins: RPS19 versus RPL5.De novo generation of HSCs from somatic and pluripotent stem cell sources.Impaired Telomere Maintenance and Decreased Canonical WNT Signaling but Normal Ribosome Biogenesis in Induced Pluripotent Stem Cells from X-Linked Dyskeratosis Congenita Patients.Dysregulation of the Transforming Growth Factor β Pathway in Induced Pluripotent Stem Cells Generated from Patients with Diamond Blackfan Anemia.Transcriptome analysis reveals a ribosome constituents disorder involved in the RPL5 downregulated zebrafish model of Diamond-Blackfan anemia.Efficient Recombinase-Mediated Cassette Exchange in hPSCs to Study the Hepatocyte Lineage Reveals AAVS1 Locus-Mediated Transgene InhibitionInduction of multipotential hematopoietic progenitors from human pluripotent stem cells via respecification of lineage-restricted precursors.LiPS-A3S, a human genomic site for robust expression of inserted transgenes.Concise Review: Getting to the Core of Inherited Bone Marrow Failures.Current status of pluripotent stem cells: moving the first therapies to the clinic.Osteosarcoma: Molecular Pathogenesis and iPSC Modeling.Molecular convergence in ex vivo models of Diamond-Blackfan anemia.Utilization of the AAVS1 safe harbor locus for hematopoietic specific transgene expression and gene knockdown in human ES cells.Ten years of iPSC: clinical potential and advances in vitro hematopoietic differentiation.Modeling Cancer with Pluripotent Stem Cells.Using induced human pluripotent stem cells to study Diamond-Blackfan anemia: an outlook on the clinical possibilities.Drug discovery for Diamond-Blackfan anemia using reprogrammed hematopoietic progenitorsLymphoblastoid cell lines from Diamond Blackfan anaemia patients exhibit a full ribosomal stress phenotype that is rescued by gene therapy.Proteolytic autodigestion: common tissue pathology in Shwachman-Diamond syndrome?Bone marrow failure and developmental delay caused by mutations in poly(A)-specific ribonuclease (PARN).Confounding in ex vivo models of Diamond-Blackfan anemia.Li-Fraumeni Syndrome Disease Model: A Platform to Develop Precision Cancer Therapy Targeting Oncogenic p53.Perspective on Diamond-Blackfan anemia: lessons from a rare congenital bone marrow failure syndrome.Critical Diamond-Blackfan anemia due to ribosomal protein S19 missense mutation.Modeling Hematological Diseases and Cancer With Patient-Specific Induced Pluripotent Stem Cells
P2860
Q26781845-D0F65B1B-FCE3-4F78-84B6-D833706EA78FQ27016090-DD5D6F8F-E7EA-4306-849A-482F6938BBADQ28078535-70769259-DB97-44B8-B198-D26C6F5E376DQ28083303-9095C514-164D-4D2E-8E49-657BE2266ECBQ33864534-A6B0B32E-44EE-4342-8CE1-AED6B847504CQ34431422-F07C2058-6B55-46EB-919D-57D2EB3A2CC7Q34465473-39A5B3F1-CE15-4C98-B253-5A4EE85B457BQ35099802-7333F22B-DCEA-4DDF-856B-79F87F8D0510Q35533599-6CD9068E-1A02-4881-B9A7-EAF20AF560EBQ35620795-A6F54183-6B6E-4D9F-871C-326ECC59CF2CQ35741406-70EDDC7A-A3E0-4F71-A6A5-050FB11E5ADAQ35951882-2BDC0F3B-C3C2-42C4-BA36-85631729C4D9Q36290454-81C8DC47-4178-41D2-959C-6179058E58A7Q37462880-20ED3A4B-2576-4EDA-BC9D-62841423F740Q37501610-00B5F2B9-BF74-418E-8376-B3F8E63D871BQ37633372-85108821-276D-4379-9984-C416B3A3CA84Q38590664-ED8B5F6D-FA8F-4C6C-BD53-7EBEE56E709AQ38653083-A68EEB50-343B-4382-9885-8A44506E868BQ38854631-858E9C82-6D34-454F-8BC5-5D5AF99700CCQ39015278-5EA52166-196D-4F47-87FA-04BB4DDB4F07Q39063423-94A5D0AD-0F8D-49C6-92C8-A326D124D867Q39306963-E5C714EE-E87E-474B-8F15-CC0682C66D2CQ39873476-A716387A-698A-45B7-967F-986999C3CF38Q40343635-A975D5D4-CDAB-44B8-B142-14B15653DCD0Q41696611-36A39002-14AF-4A14-A82F-1127C84512BAQ42724306-6729E30F-FD97-4CE4-ABBC-B101C69D9A4AQ47073215-0715274A-1C2F-492B-8F7D-D9C5A40C906EQ48276800-E3C5BD13-556C-4479-98F3-EB46DB082BBBQ48690318-FF9F1F2F-39EB-49E6-A7CD-39CACE4399DBQ49575039-EF9EA4E1-99E9-4019-A976-3F0B50CE92B2Q51530791-DDA052D2-0FDF-4269-AC77-E8794DC6B22CQ57490090-AEB7E846-C687-4D10-A48B-A4ABE71FE4A5
P2860
Ribosomal and hematopoietic defects in induced pluripotent stem cells derived from Diamond Blackfan anemia patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Ribosomal and hematopoietic de ...... mond Blackfan anemia patients.
@en
Ribosomal and hematopoietic de ...... mond Blackfan anemia patients.
@nl
type
label
Ribosomal and hematopoietic de ...... mond Blackfan anemia patients.
@en
Ribosomal and hematopoietic de ...... mond Blackfan anemia patients.
@nl
prefLabel
Ribosomal and hematopoietic de ...... mond Blackfan anemia patients.
@en
Ribosomal and hematopoietic de ...... mond Blackfan anemia patients.
@nl
P2093
P2860
P1433
P1476
Ribosomal and hematopoietic de ...... amond Blackfan anemia patients
@en
P2093
Deborah L French
Gregory M Podsakoff
Jason A Mills
Jingping Ge
Lisa M Sullivan
Loïc Garçon
Marisa Apicella
Monica Bessler
Paul Gadue
Philip J Mason
P2860
P304
P356
10.1182/BLOOD-2013-01-478321
P407
P577
2013-06-06T00:00:00Z